The FDA has warned that ketamine and compounded ketamine products aren’t approved to treat any psychiatric disorder. This usually means that they haven’t been verified to get Risk-free or efficient. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but only https://ahmadh666gwk5.topbloghub.com/profile